Efficient Prevention of Neurodegenerative Diseases by Depletion of Starvation Response Factor Ataxin-2

Georg Auburger1, Nesli-Ece Sen1, David Meierhofer2

  • 1Department of Neurology, Goethe University Medical School, 60590 Frankfurt am Main, Germany.

Insights

Ataxin-2 (ATXN2) protein is vital for cellular functions and linked to neurodegenerative diseases. Reducing ATXN2 levels effectively prevents motor neuron and cerebellar atrophy in model organisms.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Neuroscience

Background:

  • Ataxin-2 (ATXN2) homologs are conserved across eukaryotes, involved in mRNA repair, translation, and cellular metabolism.
  • ATXN2 regulates cell size, protein synthesis, and nutrient storage via mTORC1 signaling.
  • ATXN2 is essential for specific liver mitochondrial enzymes and the mitochondrial repair factor PINK1.

Purpose of the Study:

  • To investigate the multifaceted roles of Ataxin-2 (ATXN2) in cellular physiology.
  • To explore the connection between ATXN2 function and human neurodegenerative diseases.

Main Methods:

  • Analysis of ATXN2 homologs in eukaryotic organisms.
  • Investigating ATXN2's role in mRNA processing and mTORC1 signaling pathways.
  • Studying ATXN2's impact on mitochondrial function and stress granule formation.
  • Evaluating the effects of ATXN2 depletion in mouse, fly, and yeast models of neurodegeneration.

Main Results:

  • ATXN2 influences mRNA repair, translation, and cellular metabolism, including fat and glycogen storage.
  • ATXN2 is required for the function of specific liver mitochondrial enzymes and PINK1.
  • ATXN2 is upregulated during starvation and forms stress granules to manage RNA pathology.
  • Depletion of ATXN2 demonstrated significant efficacy in preventing motor neuron and cerebellar atrophy in various model systems.

Conclusions:

  • Ataxin-2 (ATXN2) plays critical roles in fundamental cellular processes and mitochondrial maintenance.
  • The study highlights ATXN2's crucial involvement in neurodegenerative disease pathogenesis.
  • Targeting ATXN2 presents a promising therapeutic strategy for preventing neuronal atrophy in neurodegenerative conditions.

Related Concept Videos